Literature DB >> 22886777

Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores.

Christopher G Goetz1, Glenn T Stebbins, Barbara C Tilley.   

Abstract

The aim of this study was to develop formulas to convert the UPDRS to Movement Disorder Society (MDS)-UPDRS scores. The MDS-UPDRS is a revision of the UPDRS with sound clinimetric properties. Reliable formulas to recalculate UPDRS scores into MDS-UPDRS equivalents are pivotal to the practical transition and definitive adoption of the MDS-UPDRS. UPDRS and MDS-UPDRS scores were collected on 875 PD patients. A developmental sample was used to regress UPDRS scores on corresponding MDS-UPDRS scores based on three H & Y groupings (I/II, III, and IV/V). Regression weighting factors and intercept terms provided formulas for UPDRS conversions to be tested in a validation sample. Concordance between the true MDS-UPDRS Part scores and those derived from the formulas was compared using Bland-Altman's plots and Lin's concordance coefficient (LCC). Significant concordance between UPDRS-estimated MDS-UPDRS scores was achieved for Parts II (Motor Experiences of Daily Living) (LCC = 0.93) and III (Motor Examination) (LCC = 0.97). The formulas resulted in mean differences between the true MDS-UPDRS and estimated MDS-UPDRS scores of less than 1 point for both Parts II and III. Concordance was not achieved for Parts I and IV (Non-motor Experiences of Daily Living and Complications of Therapy). Formulas allow archival UPDRS Parts II and III individual patient data to be accurately transferred to MDS-UPDRS scores. Because Part I collects data on much more extensive information than the UPDRS, and because Part IV is structured differently in the two versions, old ratings for these parts cannot be converted. © 2012 Movement Disorder Society.
Copyright © 2012 Movement Disorder Society.

Entities:  

Mesh:

Year:  2012        PMID: 22886777     DOI: 10.1002/mds.25122

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  48 in total

1.  Free water improves detection of changes in the substantia nigra in parkinsonism: A multisite study.

Authors:  Edward Ofori; Florian Krismer; Roxana G Burciu; Ofer Pasternak; Johanna L McCracken; Mechelle M Lewis; Guangwei Du; Nikolaus R McFarland; Michael S Okun; Werner Poewe; Christoph Mueller; Elke R Gizewski; Michael Schocke; Christian Kremser; Hong Li; Xuemei Huang; Klaus Seppi; David E Vaillancourt
Journal:  Mov Disord       Date:  2017-07-17       Impact factor: 10.338

2.  Longitudinal changes in free-water within the substantia nigra of Parkinson's disease.

Authors:  Edward Ofori; Ofer Pasternak; Peggy J Planetta; Hong Li; Roxana G Burciu; Amy F Snyder; Song Lai; Michael S Okun; David E Vaillancourt
Journal:  Brain       Date:  2015-05-16       Impact factor: 13.501

Review 3.  Deep brain stimulation.

Authors:  X L Chen; Y Y Xiong; G L Xu; X F Liu
Journal:  Interv Neurol       Date:  2013-09

4.  Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts.

Authors:  Ganqiang Liu; Joseph J Locascio; Jean-Christophe Corvol; Brendon Boot; Zhixiang Liao; Kara Page; Daly Franco; Kyle Burke; Iris E Jansen; Ana Trisini-Lipsanopoulos; Sophie Winder-Rhodes; Caroline M Tanner; Anthony E Lang; Shirley Eberly; Alexis Elbaz; Alexis Brice; Graziella Mangone; Bernard Ravina; Ira Shoulson; Florence Cormier-Dequaire; Peter Heutink; Jacobus J van Hilten; Roger A Barker; Caroline H Williams-Gray; Johan Marinus; Clemens R Scherzer
Journal:  Lancet Neurol       Date:  2017-06-16       Impact factor: 44.182

5.  Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study.

Authors:  Derek B Archer; Justin T Bricker; Winston T Chu; Roxana G Burciu; Johanna L Mccracken; Song Lai; Stephen A Coombes; Ruogu Fang; Angelos Barmpoutis; Daniel M Corcos; Ajay S Kurani; Trina Mitchell; Mieniecia L Black; Ellen Herschel; Tanya Simuni; Todd B Parrish; Cynthia Comella; Tao Xie; Klaus Seppi; Nicolaas I Bohnen; Martijn L T M Müller; Roger L Albin; Florian Krismer; Guangwei Du; Mechelle M Lewis; Xuemei Huang; Hong Li; Ofer Pasternak; Nikolaus R McFarland; Michael S Okun; David E Vaillancourt
Journal:  Lancet Digit Health       Date:  2019-08-27

6.  Commonalities and challenges in the development of clinical trial measures in neurology.

Authors:  Jesse M Cedarbaum; Diane Stephenson; Richard Rudick; Maria C Carrillo; Glenn Stebbins; Douglas Kerr; Jill Heemskerk; Wendy R Galpern; Petra Kaufmann; David Cella; Maria Isaac; Marc K Walton
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

7.  Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample.

Authors:  Petra Tomše; Luka Jensterle; Marko Grmek; Katja Zaletel; Zvezdan Pirtošek; Vijay Dhawan; Shichun Peng; David Eidelberg; Yilong Ma; Maja Trošt
Journal:  Neuroradiology       Date:  2017-04-06       Impact factor: 2.804

8.  Simplified conversion method for unified Parkinson's disease rating scale motor examinations.

Authors:  Joseph G Hentz; Shyamal H Mehta; Holly A Shill; Erika Driver-Dunckley; Thomas G Beach; Charles H Adler
Journal:  Mov Disord       Date:  2015-11-17       Impact factor: 10.338

9.  Predictors of self-perceived stigma in Parkinson's disease.

Authors:  Robert D Salazar; Emma Weizenbaum; Terry D Ellis; Gammon M Earhart; Matthew P Ford; Leland E Dibble; Alice Cronin-Golomb
Journal:  Parkinsonism Relat Disord       Date:  2018-09-25       Impact factor: 4.891

10.  The MDS-UPDRS tracks motor and non-motor improvement due to subthalamic nucleus deep brain stimulation in Parkinson disease.

Authors:  Kelvin L Chou; Jennifer L Taylor; Parag G Patil
Journal:  Parkinsonism Relat Disord       Date:  2013-07-10       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.